Clinical Laserthermia Systems AB (FRA:LS60) FFO


FRA:LS60 Clinical Laserthermia Systems AB FRA:LS60
36 GF Score
Price €0.27
GF Value €0.29
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Clinical Laserthermia Systems AB FFO?

FFO (Funds from operations) only applies to REITs.

FRA:LS60
36GF Score
Clinical Laserthermia Systems AB FRA:LS60
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Clinical Laserthermia Systems AB (FRA:LS60) Overvalued in 2026?

Based on GuruFocus' analysis, Clinical Laserthermia Systems AB stock appears to be undervalued. The current stock price of €0.27 is trading 7.9% below its estimated GF Value™ of €0.29. GuruFocus considers Clinical Laserthermia Systems AB to be Fairly Valued.

Key valuation signals for FRA:LS60:

  • FFO:
  • GF Value™: €0.29 vs. price of €0.27 (7.9% below fair value)
  • GF Score™: 36/100 with 4 warning signs

No single metric tells the full story. See the FRA:LS60 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Clinical Laserthermia Systems AB Business Description

Other Exchanges CLS B:Sweden
Address Scheelevagen 2, Medicon village, Lund, SWE, 223 81
Clinical Laserthermia Systems AB develops and sells single-use products used during each treatment procedure of treatment of solid tumors cancers. Its products include Thermal Therapy System, Mobile Laser Unit, Laser Applicator Non-cooled and Tissue Temp Probe.
36GF Score

Get the complete analysis for FRA:LS60

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.27
Price
€0.29
GF Value